Pharmacology Flashcards

1
Q

Mechanism of Penicillins.

A

D-Ala-D-Ala structural analog binds PBP transpeptidases and blocks cross-linking of peptidoglycan cell wall - build-up of precursors cause activation of autolytic enzymes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Gram+:
S. pneumo
S. pyogenes
Actinomyces

Gram- cocci:
N. meningitidis

Others:
T. pallidum

A

PROTOTYPE PENICILLINS

Penicillin G (IV/IM)
Penicillin V (PO)

May cause…
Hypersensitivity reactions
Directs Coombs+ hemolytic anemia

Resistance by…
B-lactamase (Penicillinase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Gram+:
Listeria
Enterococcus

Gram-:
E. coli
Proteus
Salmonella
Shigella
HIB
H. pylori
A

PENICILLINASE-SENSITIVE PENICILLINS

Amoxicillin (greater oral bioavailability)
Amoxicillin-Clavulanate (Augmentin)
Ampicillin
Ampicillin-Sulbactam (Unasyn)

May cause…
Hypersensitivity reactions
Pseudomembranous colitis

Resistance by…
B-lactamase (Penicillinase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Gram+

S. aureus (not MRSA)

A

PENICILLINASE-RESISTANT PENICILLINS

Bulky R group blocks binding of B-lactamase

Dicloxacillin
Nafcillin
Oxacillin

May cause…
Hypersensitivity reactions
Interstitial nephritis

Resistance by…
Altered PBP target site on MRSA
ESBL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Gram-:
Enteric rods
Pseudomonas

A

ANTIPSEUDOMONAL PENICILLINS

Piperacillin-Tazobactam (Zosyn)
Ticarcillin-Clavulanate (Co-Ticarclav)

May cause…
Hypersensitivity reactions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanism of Cephalosporins.

A

D-Ala-D-Ala structural analog binds PBP transpeptidases and blocks cross-linking of peptidoglycan cell wall - Excess precursors cause activation of autolytic enzymes

More resistant to B-lactamases than Penicillins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Gram+:
Presurgical coverage of S. aureus
Cocci (staph/strep)

Gram-:
E. coli
Klebsiella
Proteus

A

1ST GENERATION CEPHALOSPORINS

Cefazolin
Cephalexin

May cause...
Hypersensitivity reactions
Autoimmune hemolytic anemia
Disulfiram-like reaction
Vit K deficiency
Increases nephrotoxicity of Aminoglycosides

Resistance by…
Structural changes in PBP
ESBL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gram+:
Cocci

Gram-:
E. coli
Klebsiella
Proteus
Neisseria
HIB
Enterobacter
Serratia
A

2ND GENERATION CEPHALOSPORINS

Cefaclor
Cefoxitin

May cause...
Hypersensitivity reactions
Autoimmune hemolytic anemia
Disulfiram-like reaction
Vit K deficiency
Increases nephrotoxicity of Aminoglycosides

Resistance by…
Structural changes in PBP
ESBL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Serious Gram- infections

A

3RD GENERATION CEPHALOSPORINS

Ceftriaxone (Neisseria, disseminated Lyme)
Ceftazidime (Pseudomonas)

May cause...
Hypersensitivity reactions
Autoimmune hemolytic anemia
Disulfiram-like reaction
Vit K deficiency
Increases nephrotoxicity of Aminoglycosides

Resistance by…
Structural changes in PBP
ESBL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Serious Gram- infections

Increased activity against Pseudomonas

A

4TH GENERATION CEPHALOSPORINS

Cefepime

May cause...
Hypersensitivity reactions
Autoimmune hemolytic anemia
Disulfiram-like reaction
Vit K deficiency
Increases nephrotoxicity of Aminoglycosides

Resistance by…
Structural changes in PBP
ESBL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Broad Gram- and Gram+ coverage
MRSA
Does not cover Pseudomonas.

A

5H GENERATION CEPHALOSPORINS

Ceftaroline

May cause...
Hypersensitivity reactions
Autoimmune hemolytic anemia
Disulfiram-like reaction
Vit K deficiency
Increases nephrotoxicity of Aminoglycosides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mechanism of Carbapenems.

A

D-Ala-D-Ala structural analog binds PBP transpeptidases and blocks cross-linking of peptidoglycan cell wall - build-up of precursors cause activation of autolytic enzymes

B-lactamase resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Life-threatening…
Gram+ cocci
Gram- rods (e.g. ESBL)
Anaerobes

A

CARBAPENEMS

Ertapenem
Meropenem (decreased seizure risk)
Imipenem-Cilastatin (decreased deactivation in renal tubules by dehydropeptidase I)

May cause…
GI distress
Skin rash
Seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mechanism of Monobactams.

A

D-Ala-D-Ala structural analog binds PBP transpeptidases and blocks cross-linking of peptidoglycan cell wall - build-up of precursors cause activation of autolytic enzymes

More resistant to B-lactamases than Penicillins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Gram- rods for Penicillin-allergic patients, or those with renal insufficiency who can’t tolerate Aminoglycosides.

Note - Pseudomonal coverage

A

MONOBACTAMS

Aztreonam

May cause…
Occasional GI upset

Resistance by…
ESBL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mechanism of Glycopeptides (Vancomycin, Bacitracin).

A

Inhibits cell wall peptidoglycan synthesis formation by binding D-ala-D-ala portion of cell wall glycoproteins - Prevents transpeptidase from making cross-links

B-lactamase resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
Serious Gram+:
MRSA (drug-resistant)
S. epidermidis (biofilm producing)
Enterococcus
Clostridium difficile (bacteriostatic)
A

VANCOMYCIN

May cause...
Nephrotoxicity
Ototoxicity
Thrombophlebitis
Flushing (Red Man Syndrome) - prevent with antihistamines

Resistance by…
Amino acid modification to D-ala-D-lac

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Mechanism of Aminoglycosides.

A

Inhibits protein synthesis by irreversible inhibition of initiation complex via binding to 30S subunit

Misreading of mRNA

Synergistic with B-lactams/Vanc - Help it enter the cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Severe Gram- rod infections (e.g. endocaditis)
Bowel surgery

Note - Ineffective against Anaerobes

A

AMINOGLYCOSIDES

Amikacin
Gentamycin
Neomycin (bowel surgery)
Streptomycin
Tobramycin
May cause..
Nephrotoxicity
Ototoxicity (with loop diuretic)
Neuromuscular blockade
Teratogen (Ototoxicity)

Resistance by…
Transferase inactivation of drug
Mutated Ribosome
Mutated Porin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mechanism of Tetracyclines.

A

Inhibits protein synthesis by binding to 30S and preventing attachment of aminoacyl-tRNA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Borrelia burgdorferi
Mycoplasma
Rickettsia/Chlamydia (intracellular accumulation)
Propionibacterium acnes

Do not take with milk (Ca), antacids (Ca, Mg) or Fe as divalent cations inhibit gut absorption

A

TETRACYCLINES

Tetracycline
Doxycycline (fecal elimination; renal failure patients)
Minocycline
Tigecycline (MRSA coverage)

May cause…
GI distress/Pill esophagitis
Photosensitivity
Teratogen (Teeth, Bone)

Resistance by…
Decreased uptake or increased efflux by plasmid-encoded transport pumps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Mechanism of Chloramphenicol.

A

Inhibits protein synthesis by blocking peptidyl transferase at 50S, preventing transfer of growing polypeptide strand to A site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HIB meningitis
N. meningitidis
S. pneumo meningitis
Rickettsia rickettsii

Toxic but low cost

A

CHLORAMPHENICOL

May cause…
Dose dependent anemia
Dose independent aplastic anemia
Gray baby syndrome if premature (no UDPGT)

Resistance by…
Plasmid-encoded acetyltransferase inactivates drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Mechanism of Clindamycin.

A

Inhibits protein synthesis by blocking peptide transfer at 50S subunit from A site to P site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Anaerobes above the diaphragm: Clostridium perfringens Bacteroides (anaerobic lung abscess) Gram+: Invasive GAS pyogenes
CLINDAMYCIN May cause... Pseudomembranous colitis
26
Mechanism of Oxazolidinones.
Inhibits protein synthesis by binding to 50S subunit and preventing formation of initiation complex.
27
Gram+ species including MRSA and VRE.
OXAZOLIDINONES Linezolid May cause... Serotonin syndrome Bone marrow suppression/Thrombocytopenia Peripheral neuropathy Resistance by... Point mutation of rRNA
28
Mechanism of Macrolides.
Inhibit protein synthesis by binding to 23S rRNA of 50S subunit to block translocation. Note - Fidaxomicin inhibits the sigma subunit of RNA polymerase instead
29
Atypical pneumonia (Myco/Legion/Chlamy) Chlamydia B. pertussis Prophylaxis for mycobacterium avium (CD4 < 50) Strep infections in Penicillin-allergic patients Note - Increases serum concentration of anticoagulants Note - Using a P450 inhibitor increases blood levels
MACROLIDES Azithromycin Clarithromycin (P450 inhibition) Erythromycin (P450 inhibition) Fidaxomicin (treats c. diff) ``` May cause... Prolonged QT Gastrointestinal motility issues Cholestatic hepatitis Rash Eosinophilia Myopathy with Statins (metabolized by P450) ``` Resistance by... Methylation of 23S rRNA-binding site
30
Mechanism of Sulfonamides and Dapsone.
Inhibit folate synthesis via inhibition of dihydropteroate synthase.
31
Gram+ Gram- Nocardia Chlamydia Displaces other drugs from albumin (e.g. Warfarin)
SULFONAMIDES Sulfamethoxazole (SMX) Sulfisoxazole Sulfadiazine ``` May cause (slow acetylators)... Hypersensitivity reactions Photosensitivity Hemolysis in G6PD deficiency Tubulointerstitial nephritis Kernicterus in infants ``` Resistance by... Altered dihydropteroate synthase Decreased uptake Increased PABA (precursor) synthesis
32
Leprosy
DAPSONE Combine with Rifampin May cause... Hemolysis in G6PD deficiency Methemoglobinemia
33
Mechanism of Trimethoprim.
Inhibits folate synthesis by inhibiting Dihydrofolate Reductase and thus THF production Note - Sulfamethoxazole inhibits an earlier enzyme (dihydropteroate synthetase)
34
``` UTI (E. coli, Klebsiella, Proteus) Salmonella Shigella Pneumocystis Pneumocystis prophylaxis (CD4 < 200) Toxoplasmosis prophylaxis (CD4 < 100) Nocardia ("SNAP") ```
TRIMETHOPRIM-SULFAMETHOXAZOLE ``` May cause... Megaloblastic anemia (folate deficiency) Leukopenia (folate deficiency) Granulocytopenia (folate deficiency) Teratogen (neural tube defects) Hyperkalemia ```
35
Mechanism of Fluoroquinolones.
Inhibits DNA replication by inhibition of topoisomerase II (DNA gyrase) and topoisomerase IV.
36
Gram- rods (GU/GI) Pseudomonas Neisseria Note - Do not take with milk (Ca), antacids (Ca, Mg) or Fe as divalent cations inhibit gut absorption
FLUOROQUINOLONES Ciprofloxacin Levofloxacin (Respiratory) ``` May cause... Myalgia Tendonitis/tendon rupture (>60 y/o, with prednisone) Cartilage damage (children, pregnant/nursing mothers) Prolonged QT Skin rash Headache and dizziness GI upset ``` Resistance by... Mutation in DNA gyrase or efflux pumps
37
Mechanism of Daptomycin.
Lipopeptide disrupts cell membrane of Gram+ cocci.
38
S. aureus (MRSA) cellulitis, bacteremia, endocarditis VRE Note - Cannot be used in pneumonia due to surfactant inactivation
DAPTOMYCIN May cause... Myopathy Rhabdomyolysis
39
Mechanism of Metronidazole.
Forms toxic free radical metabolites which damage DNA.
40
Anaerobic infections below the diaphragm: Clostridium difficile Bacteroides ``` ("GET Going on the METRO") Giardia Entamoeba Trichomonas Gardnerella vaginalis ``` Triple therapy for H. pylori
METRONIDAZOLE May cause... Disulfiram-like reaction Metallic taste Headache
41
Mechanism of Rifamycins.
Inhibits DNA-dependent RNA polymerase.
42
RIPE drug Delay resistance to Dapsone when used for leprosy Meningococcal prophylaxis HIB chemoprophylaxis for close contacts
RIFAMYCINS Rifampin (increased cytochrome P-450 - avoid in HIV) Rifabutin (combine with Dapsone for leprosy) May cause... Orange body fluids Resistance by... Monotherapy rapidly leads to reduced binding to RNA polymerase
43
Mechanism of Isoniazid
Decreased synthesis of mycolic acids in mycobacterial cell wall - Requires activation by catalase-peroxidase (KatG)
44
RIPE drug Only agent used as solo prophylaxis against TB Monotherapy for latent TB Given with Pyridoxine (vit B6)
ISONIAZID May cause... Hepatotoxicity (slow acetylators) Vit B6 deficiency Resistance by... Underexpression of KatG
45
RIPE drug working in host phagolysosomes.
PYRAZINAMIDE May cause... Hepatotoxicity Hyperuricemia
46
RIPE drug - Decreases carbohydrate polymerization (cell wall) by blocking arabinosyltransferase
ETHAMBUTOL ``` May cause... Optic neuropathy (R-G color blindness) ```
47
Second line TB drug interfering with 30S component of ribosome.
STREPTOMYCIN ``` May cause... Tinnitus Vertigo Ataxia Nephrotoxicity ```
48
Prophylaxis for patients at high risk of endocarditis.
Amoxicillin
49
Prophylaxis for history of recurrent UTIs.
TMP-SMX
50
Prophylaxis following exposure to meningococcal infection.
Ceftriaxone Ciprofloxacin Rifampin
51
Prophylaxis for... Pregnant women with GBS Strep pharyngitis with prior rheumatic fever Exposure to syphilis
Penicillin G
52
Treatment for multidrug resistant Pseudomonas or Acinetobacter.
Polymyxins B and E (colistin)
53
``` Serious systemic mycoses (intrathecally for meningitis)... Aspergillosis Histoplasma Blastomyces Coccidioides Cryptococcus Candida Mucor ```
AMPHOTERICIN B Binds ergosterol (unique to fungi) forming membrane pores that allow leakage of electrolytes through cell wall Supplement K and Mg because of altered renal tubule permeability ``` May cause... Fever/chills (shake and bake) Hypotension Nephrotoxicity (hydrate) Electrolyte abnormalities Anemia (low EPO) IV phlebitis ```
54
Rinse for oral candidiasis | Topical for diaper or vaginal candidiasis
NYSTATIN Same mechanism as Amphotericin B - too toxic to be used systemically
55
Systemic fungal infections | Cryptococcal meningitis with AmphoB
FLUCYTOSINE Inhibits DNA and RNA biosynthesis by conversion to 5-fluorouracil by cytosine deaminase May cause... Bone marrow suppression
56
Mechanism and side effects of Azoles.
Inhibit fungal Ergosterol synthesis via inhibition of cytochrome P-450 - Converts Lanosterol to Ergosterol May cause... Testosterone synthesis inhibition (i.e. Ketoconazole) Liver dysfunction
57
Chronic suppression of cryptococcal meningitis in AIDS | Candidal infections
Fluconazole
58
Blastomyces Coccidioides Histoplasma
Itraconazole
59
Topical fungal infections
Clotrimazole | Miconazole
60
Dermatophytoses (i.e. onychomycosis)
TERBINAFINE Inhibits fungal enzyme Squalene Epoxidase - Inhibiting Ergosterol synthesis ``` May cause... Hepatotoxicity Taste disturbance GI upset Headaches ```
61
Mechanism of Echinocandins.
Inhibit cell wall synthesis by inhibiting synthesis of B-glucan.
62
Invasive aspergillosis | Candida
ECHINOCANDINS Caspofungin Anidulafungin Micafungin May cause... Flushing (histamine release) GI upset
63
Oral treatment of superficial infections especially dermatophytes (tinea, ringworm).
GRISEOFULVIN Interferes with microtubule function disrupting mitosis - deposits in keratin-containing tissues ``` May cause... Teratogenic Carcinogenic Confusion Headaches ```
64
Mechanism and side effects of scabies and lice (Pediculus, Pthirus) treatment. ("PML NAGs you")
Permethrin - Na channel blocker (neurotoxicity) Malathion - AchE Lindane - GABA blockade (neurotoxicity)
65
Treatment of plasmodial species other than P. falciparum.
CHLOROQUINE Blocks detoxification of heme into hemozoin - heme accumulates and is toxic to plasmodium Resistance in P. falciparum due to membrane pump that decreases intracellular concentration May cause... Retinopathy Pruritus
66
Treatment of P. falciparum.
Mefloquine Atovaquone/Proguanil Artemether/Lumefantrine
67
Treatment of life-threatening malaria.
Quinidine | Artesunate
68
Treatment and prevention of Influenza A/B.
OSELTAMIVIR, ZANAMIVIR Inhibits influenza neuraminidase - Impaired release of viral progeny
69
Mechanism and adverse effects of -cyclovirs Includes... Acyclovir Valacyclovir Famciclovir
Guanosine nucleoside analogs that are monophosphorylated by HSV/VZV Thymidine Kinase leading to DNA chain termination - Not phosphorylated in uninfected cells and so few adverse effects May cause... Obstructive crystalline nephropathy/ARF (hydration) Resistance by... Mutated viral thymidine kinase
70
CMV in immunocompromised patients.
GANCICLOVIR 5'-monophosphate nucleoside formed by CMV viral kinase - Preferentially inhibits viral DNA polymerase May cause... Bone marrow suppression (leukopenia, neutropenia, thrombocytopenia) Renal toxicity Resistance by... Mutated viral kinase
71
Ganciclovir-resistant CMV Acyclovir-resistant HSV Note - Pyrophosphate analog
FOSCARNET Does not require viral kinase ``` May cause... Nephrotoxicity Hypocalcemia (calcium chelator) Hypomagnesemia Seizures ``` Resistance by... Mutated DNA polymerase
72
Ganciclovir-resistant CMV retinitis Acyclovir-resistant HSV Note - Nucleotide analog
CIDOFOVIR Does not require viral kinase May cause... Nephrotoxicity (given with Probenecid and IV NaCl)
73
Ideal regimen for HAART.
2 NRTIs + 1 integrase inhibitor
74
Mechanism and adverse effects of NRTIs ``` Includes... Tenofovir ZiDOVudine LAMivudine ABACAvir DIDanosine EMtricitabine ```
Competitively inhibit nucleotide binding to reverse transcriptase and terminate chain (lack 3' OH) - Only Tenofovir (nucleotide) does not need to be phosphorylated ``` May cause... Bone marrow suppression (give G-CSF) Type IV hypersensitivity with HLA-B57:01 (Abacavir) Lipodystrophy Pancreatitis (Didanosine) Lactic acidosis (not Tenofovir) ```
75
NRTI for general prophylaxis and during pregnancy.
Zidovudine
76
Adverse effects of NNRTIs Includes... EfaVIRenz NeVIRapine DelaVIRdine
Bind at different site than NRTIs - do not require phosphorylation ``` May cause... SJS-TEN Hepatotoxicity Vivid dreams (Efavirenz) Teratogen (Efavirenz, Delavirdine) ```
77
Mechanism of Protease Inhibitors (-NAVIR).
Prevent maturation of new viruses by preventing cleaving of polypeptide products into functional parts
78
Protease inhibitor which can boost other drug concentrations by inhibiting cytochrome P-450.
RITONAVIR Alternatively - Rifampin contraindicated with PIs due to induction of P-450 ``` May cause... Hyperglycemia Lipodystrophy (Cushing-like) GI intolerance Nephropathy Hematuria (Indinavir) ```
79
Mechanism of integrase inhibitors (-Gravir).
Inhibits HIV genome integration into host cell - Prevent mRNA transcription by RNA Pol III May cause... Elevated CK
80
Mechanism of fusion inhibitors (EnFUvirtide, Maraviroc).
Maraviroc binds CCR5 on surface of T cells/monocytes inhibiting interaction with gp120 Enfuvirtide binds gp41 inhibiting viral entry May cause... Skin reaction at injection site
81
Chronic HBV, HCV Kaposi sarcoma Hairy cell leukemia Condyloma cuminatum
INF-A IFN-b used in MS, and IFN-y used in CGD ``` May cause... Flu-like symptoms Depression Neutropenia Myopathy ```
82
Treats HCV by inhibiting synthesis of guanine nucleotides by competitively inhibiting inosine monophosphate dehydrogenase.
RIBAVIRIN May cause... Hemolytic anemia Severe teratogen
83
Treats HCV by inhibiting RNA-dependent RNA polymerase acting as a chain terminator.
SOFOSBUVIR Not monotherapy - use with Ribavirin or Peginterferon alfa May cause... Fatigue Headaches Nausea
84
Treats HCV by inhibiting protease preventing viral replication.
SIMEPREVIR Not monotherapy - use with Ledipasvir (NS5A inhibitor) May cause... Photosensitivity Rash
85
``` Mechanism of action of... Alcohol Chlorhexidine Hydrogen Peroxide Iodide ```
Cell membrane disruption, Protein denaturation Cell membrane disruption, Cytoplasm coagulation Free radical production (sporicidal) Halogenation of proteins/nucleic acids (sporicidal)
86
Antibiotics to avoid in pregnancy. | "SAFe Children Take Really Good Care"
``` Sulfonamides (kernicterus, neural tube) Aminoglycosides (ototoxicity) Fluoroquinolones (cartilage damage) Clarithromycin (embryotoxic) Tetracycline (discolored teeth, inhibition of bone growth) Ribavirin (teratogen) Griseofulvin (teratogen) Chloramphenicol (gray baby syndrome) ```
87
Bactericidal antibiotics | "Very Finely Proficient At Cell Murder"
``` Vancomycin Fluoroquinolones Penicillin Aminoglycosides Cephalosporins Metronidazole ``` Also... TMP-SMX
88
Relationship of Km and Vmax in Michaelis-Menten plot.
Km = [S] at 1/2Vmax Km = Inversely related to affinity of the enzyme for its substrate (i.e less substrate required to reach 1/2Vmax) Vmax = directly proportional to enzyme concentration
89
Km, Vmax, and slope in Lineweaver-Burk plot.
``` Slope = Km/Vmax 1/Vmax = y-intercept -1/Km = x-intercept ``` Noncompetitive inhibitors change y-intercept Competitive inhibitors change x-intercept
90
Effect of reversible competitive antagonists Resembles substrate Binds active site Overcome by increasing [S]... Vmax Km/EC50 Pharmacodynamics
Unchanged Increased Decreased potency E.g. Flumazenil
91
Effect of irreversible competitive antagonists Resembles substrate Binds active site Not overcome by increasing [S]... Vmax Km/EC50 Pharmacodynamics
Decreased Unchanged Decreased efficacy
92
Effect of noncompetitive antagonists Does not resemble substrate Does not bind active site Not overcome by increasing [S]... Vmax Km/EC50 Pharmacodynamics
Decreased Unchanged Decreased efficacy E.g. Phenoxybenzamine
93
Volume of distribution (Vd).
Amount in body/Amount in plasma ``` Low = 3-5 L (plasma) Medium = 15 L (interstitial) High = 40 L (intracellular) ```
94
Effect of liver and kidney disease on Vd (decreased protein binding).
Increased Vd
95
Vd of large/charged molecules and plasma bound proteins.
Low (blood)
96
Vd of small hydrophilic molecules.
Medium (CSF)
97
Vd of small lipophilic molecules, especially if bound to tissue protein.
Large (all tissues including fat)
98
Clearance (CL).
Rate of elimination/Plasma concentration OR Vd x Ke (elimination constant) - increased Vd means more volume has to be cleared per same unit time to excrete the same amount of drug
99
Half-life for first-order kinetics drug.
(0.7 x Vd)/CL 4-5 half-lives to reach steady state (independent of loading/maintenance dosing)
100
Loading dose.
(Cp x Vd)/F ``` Cp = target plasma concentration at steady state F = bioavailability or (AUC PO x IV dose)/(AUC IV x PO dose) ``` Unchanged in renal/liver disease
101
Maintenance dose.
(Cp x CL x T)/F T = dosage interval if not administered continuously Decreased in renal/liver disease Note - CL and T should match in units (minutes or hours)
102
Type of interaction describing required presence of cortisol for full effect of catecholamine response.
Permissive interaction
103
Acute decrease in response to a drug after initial/repeated administration (MDMA, LSD).
Tachyphylactic
104
Difference between additive and synergistic interactions.
In additive the total effect is equal to the sum of the individual effects (e.g. APAP, ASA), while in synergistic the total effect is only higher than each individual effect (e.g. Clopidogrel, ASA).
105
Rate of elimination is constant regardless of Cp (plasma concentration) - constant amount of drug is eliminated per unit time so that Cp decreases linearly with time.
ZERO-ORDER ELIMINATION Capacity-limited elimination - Phenytoin, Ethanol, ASA at toxic doses Half-life is not constant - decreases with decreasing concentration
106
Rate of elimination is directly proportional to Cp - constant fraction of drug is eliminated per unit time so that Cp decreases exponentially with time.
FIRST-ORDER ELIMINATION Flow-dependent elimination - most drugs Half-life is constant
107
Mechanism of NaHCO3 induced elimination of weak acids (ASA, Phenobarbital, Methotrexate).
Trapped in basic environment - alkalinization of weak acid (protonated HA) makes species charged (A-), trapping it in the urine for elimination
108
Mechanism of NH4Cl induced elimination of weak bases (Amphetamines).
Trapped in acidic environment - acidification of a weak base (deprotonated B) makes species charged (protonated BH+), trapping it in the urine for elimination Note - Alternatively some weak bases (TCAs) are treated by NaHCO3 rather than elimination. Alkalinization of a base (protonated BH+) makes species uncharged (deprotonated B), allowing it to move out of the blood and back into fat to be secreted slowly over time
109
Phase I drug metabolism - lost in geriatric patients.
Redox Hydrolysis with cytochrome P-450 Slightly polar, often active product
110
Phase II drug metabolism - maintained in geriatric patients.
Conjugation (Methylation, Glucuronidation, Acetylation, Sulfation) Very polar, inactive metabolites for renal elimination
111
Pharmacokinetic measure of efficacy - maximum effect a drug can have.
Vmax - Increased y-value = increased Vmax Partial agonists have less efficacy than full agonists
112
Pharmacokinetic measure of potency - amount needed for a given effect.
EC50 - left-shifting = decreased EC50 = increased potency
113
Effect of partial agonist Binds active site... Vmax Km/EC50 Pharmacodynamics
Decreased Independent Decreased efficacy E.g. Buprenorphine
114
Therapeutic index.
TD50/ED50
115
Therapeutic window
TD50 - ED50
116
Only sympathetic target organs innervated by cholinergic fibers.
``` Sweat glands (M) Adrenal medulla (Nn - same as autonomic ganglia) ```
117
Innervation type and receptor for somatic system.
Cholinergic innervation | Nm receptor
118
Mechanism of nicotinic Ach receptors.
Ligand-gated Na/K channels
119
Increased vascular smooth muscle contraction (inc. SBP) Increased pupillary dilator muscle contraction (mydriasis) Increased intestinal/bladder sphincter muscle contraction
a1
120
``` Decreased adrenergic outflow Decreased insulin release Decreased lipolysis Decreased aqueous humor production Increased platelet aggregation ```
a2 Autoreceptor - often on presynaptic membrane for feedback inhibition
121
Increased heart rate Increased contractility Increased renin release Increased lipolysis
b1
122
``` Vasodilation (dec. DBP) Bronchodilation Increased insulin release Increased lipolysis Increased aqueous humor production Decreased uterine tone (tocolysis) Decreased ciliary muscle tone ```
b2 Note - a2 inhibition of insulin release predominates over b2 induced release
123
Increased lipolysis | Increased thermogenesis in skeletal muscle
b3
124
Parasympathetic receptor acting in CNS and enteric nervous system
M1
125
Decreased heart rate | Decreased atrial contractility
M2
126
Bronchoconstriction Increased exocrine gland secretion Increased insulin secretion Increased gut peristalsis Increased bladder contraction Increased pupillary sphincter muscle contraction (miosis) Increased ciliary muscle contraction (accommodation)
M3
127
Receptor relaxing renal vascular smooth muscle
D1
128
Receptor modulating transmitter release (CNS)
D2
129
``` Increased nasal and bronchial mucus production Increased vascular permeability Increased contraction of bronchioles Pruritus Pain ```
H1
130
Receptor increasing gastric acid secretion in addition to M3
H2
131
Receptor increasing vascular smooth muscle contraction in addition to a1
V1
132
Receptor increasing H2O permeability and resorption in collecting tubules of kidneys
V2
133
G-protein class of all G-protein-linked 2nd messengers - a1, a2, b1, b2, b3, M1, M2, M3, D1, D2, H1, H2, V1, V ("After QISSeS you get a QIQ out of SIQ Super Qinky Sex")
``` a1 = q a2 = i b1 = s b2 = s b3 = s M1 = q M2 = i M3 = q D1 = s D2 = i H1 = q H2 = s V1 = q V2 = s ```
134
Mechanism of Gq receptors
Activates Phospholipase C Converts PIP2 to DAG and IP3 DAG activates Protein Kinase C IP3 increases Ca influx (smooth muscle contraction)
135
Mechanism of Gs receptors
``` Activates Adenylate cyclase Converts ATP to cAMP Activates Protein Kinase A Phosphorylation of Phospholamban Increased Ca influx Increased inotropy ``` cAMP-dependent Protein Kinase A (PKA) activated Inhibition of Myosin light chain kinase Vasodilatation
136
Mechanism of Gi receptors
Inhibition of Adenylate cyclase
137
NE/Amphetamine interaction in synaptic cleft
Amphetamines use NET to enter presynaptic terminal Use VMAT to enter neurosecretory vesicles Displace NE from vesicles NE reaches conc. threshold in presynaptic terminal NET action is reversed and NE is expelled
138
Mechanism for hypertensive crisis in patients taking MAOi
Tyramine normally degraded by MAO Excess Tyramine enters presynaptic vesicles Other neurotransmitters (e.g. NE) displaced Increased active presynaptic neurotransmitters Increased diffusion into synaptic cleft Increased sympathetic stimulation
139
Mechanism of Reserpine
Inhibits uptake of Dopamine into vesicles (antipsychotic) where conversion to NE takes place (antihypertensive)
140
Mechanism and use of Bethanechol
Cholinomimetic - Activates bowel and bladder smooth muscle (M3) and is resistant to AChE Postoperative ileus Neurogenic ileus Urinary retention
141
Mechanism and use of Carbachol
Cholinomimetic direct agonist - Copy of acetylcholine Glaucoma
142
Mechanism and use of Methacholine
Cholinomimetic direct agonist - Stimulates muscarinic receptors in airway when inhaled Asthma challenge test
143
Mechanism and use of Pilocarpine
Cholinomimetic direct agonist... Contracts ciliary muscle of eye Contracts pupillary sphincter Open-angle glaucoma (ciliary) Closed-angle glaucoma (pupillary) Xerostomia in Sjogren's (sweat, tears, saliva) Note - Resistant to AchE
144
Mechanism and use of Donepezil, Galantamine, and Rivastigmine
Cholinomimetic indirect agonist/anticholinesterase Alzheimer's Note - Can also treat with Vit E (antioxidant)
145
Mechanism and use of Edrophonium
Cholinomimetic indirect agonist/anticholinesterase Diagnosis of Myasthenia Gravis - If response then increase AchEi dose, if no response then cholinergic crisis and stop AchEi
146
Mechanism and use of Neostigmine
Cholinomimetic indirect agonist/anticholinesterase ``` No CNS penetration (quaternary amine) Postoperative ileus Neurogenic ileus Urinary retention Myasthenia gravis Postoperative NMJ blockade reversal ```
147
Mechanism and use of Physostigmine
Cholinomimetic indirect agonist/anticholinesterase Crosses blood-brain barrier (tertiary amine) Atropine overdose
148
Mechanism and use of Pyridostigmine
Cholinomimetic indirect agonist/anticholinesterase No CNS penetration (quaternary amine) Myasthenia gravis
149
Diseases exacerbated by cholinomimetic agents.
``` Asthma (M3 bronchoconstriction) COPD (M3 bronchoconstriction) Peptic ulcers (M3 exocrine secretion) ```
150
``` Diarrhea Urination Miosis Bronchospasm Bradycardia Excitation of skeletal muscle/CNS Lacrimation Sweating Salivation ```
ORGANOPHOSPHATE POISONING Atropine - Competitive inhibitor of muscarinic receptors Pralidoxime (2-PAM) for nicotinic symptoms - regenerates AChE
151
Mechanism and use of Benztropine
Muscarinic antagonist Parkinson's disease Acute dystonia
152
Mechanism and use of Glycopyrrolate
Muscarinic antagonist Preoperative reduction in airway secretions Drooling Peptic ulcers
153
Mechanism and use of Hyoscyamine, Dicyclomine
Muscarinic antagonist Antispasmodics for IBS
154
Mechanism and use of Ipratropium, Tiotropium
Muscarinic antagonist - Reduce bronchoconstriction and mucus production COPD Asthma
155
Mechanism and use of Oxybutynin, Solifenacin, Tolterodine
Muscarinic antagonist Overactive bladder
156
Mechanism and use of Atropine, Homatropine, Tropicamide
Muscarinic antagonist RCA MI (reduces vagal tone/bradycardia) Mydriasis induction Cycloplegia ``` May cause... Hot as a hare (decreased sweating) Dry as a bone Red as a beet Blind as a bat Mad as a hatter Bowel and bladder lose their tone Heart runs alone (tachycardia) Increased IOP/Glaucoma ```
157
Gardener with mydriasis.
Gardener's pupil Due to Jimson weed (Datura) an alkaloid with muscarinic antagonist action
158
Target receptor and use of Albuterol, Salmeterol
b2 > b1 agonist Asthma COPD
159
Target receptor and use of Dobutamine
b1 >> b2, a1 agonist - Increased cAMP causes increased intracellular Ca (inotropy) and nodal Na channel activation (chronotropy) Refractory HF Cardiogenic shock (acute MI) Cardiac stress testing May increase oxygen requirement and thus potentiate ischemia Note - Little effect on PVR
160
Target receptor and use of Dopamine
D1 = D2 > b > a agonist Note - beta induced inotropy/chronotropy and low doses, alpha induced vasoconstriction at higher doses Shock Heart failure Bradycardia
161
Target receptor and use of Epinephrine
b > a agonist Note - Alpha effects predominate at higher doses increasing diastolic BP (decreased at low doses) Anaphylaxis Asthma
162
Target receptor and use of Fenoldopam
D1 agonist Postoperative hypertension Hypertensive crisis with renal failure Promotes natriuresis May cause... Hypotension Tachycardia
163
Target receptor and use of Isoproterenol
Non-selective b agonist Evaluation of tachyarrhythmias May worsen ischemia
164
Target receptor and use of Midodrine
a1 agonist Autonomic insufficiency/Postural hypotension May exacerbate supine hypertension
165
Target receptor and use of Norepinephrine
a1 >> a2 > b1 agonist Hypotension Shock
166
Target receptor and use of Phenylephrine/Pseudoephedrine
a1 > a2 agonist Hypotension Ocular procedures (pupillary dilator) Rhinitis (decongestant) May cause... HTN CNS stimulation/anxiety
167
Mechanism and use of Amphetamines
Indirect general agonist (promotes release) and reuptake inhibitor Narcolepsy ADHD Obesity
168
Mechanism and side effects of Cocaine
Blocks dopamine reuptake channel ``` Vasoconstriction (DAT binding) Local anesthesia (Na channel blockade) ```
169
``` Sympathomimetic and mechanism resulting in... Dramatically increased PVR Increased MAP Decreased HR Widened pulse pressure No change in CO ```
NOREPINEPHRINE (a1 > a2 > b1) Dramatic increase in PVR due to unopposed a1 Greater increase in systolic pressure (via b1) relative to increase in diastolic (high PVR = high venous return) Widened pulse pressure and increased MAP resulting in reflex bradycardia - no net effect on CO
170
``` Sympathomimetic and mechanism resulting in... Decreased PVR Slightly increased MAP Increased HR Widened pulse pressure Increased in CO ```
EPINEPHRINE (b > a) Decrease in PVR and diastolic BP via b2 > a1 (low doses) Increased systolic pressure (less than NE) due to increased contractility and HR via b1 Widened pulse pressure and slightly increased MAP - increased CO overall
171
Mechanism and use of Clonidine, Guanfacine
Sympatholytic - a2 agonists Hypertensive urgency ADHD Tourette's ``` May cause... CNS depression Bradycardia Hypotension Respiratory depression Miosis Rebound hypertension (Clonidine) ```
172
Mechanism and use of a-Methyldopa
Sympatholytic - a2 agonists Hypertension in pregnancy May result in... Direct Coombs+ hemolysis SLE-like syndrome
173
Mechanism and use of Phenoxybenzamine
Nonselective, irreversible a-blocker Preoperative Pheochromocytoma to prevent hypertensive crisis May cause... Orthostatic hypotension with reflex tachycardia
174
Mechanism and use of Phentolamine
Nonselective, reversible a-blocker Given to patients on MAOi who eat Tyramine May cause... Orthostatic hypotension with reflex tachycardia
175
Mechanism and use of Prazosin, Terazosin, Doxazosin, Tamsulosin
a1 selective a-blocker BPH PTSD (Prazosin) Hypertension May cause on first dose... Orthostatic hypotension Note - Tamsulosin cannot be used in HTN as it is selective for a1-AD (prostate) rather than a1B (vascular)
176
Mechanism and use of Mirtazapine
a2 selective a-blocker Depression May cause... Sedation Increased appetite Increased serum cholesterol
177
``` Mechanism of b-blocker treatment of... Angina/MI SVT (Metoprolol, Esmolol) Hypertension HF (Metoprolol, Carvedilol, Bisoprolol) Glaucoma (Timolol) Variceal bleeding (Propranolol, Nadolol) ```
``` Decreased HR/Inotropy decrease O2 demand Decreased AV conduction velocity Decreased CO/Renin (b1 on JGA cells) Decreased sympathetic activation Decreased secretion of aqueous humor Decreased hepatic venous pressure gradient/portal HTN ```
178
Adverse effects of b-blockers
``` Erectile dysfunction Bradycardia AV block Asthma/COPD exacerbation HF Seizures Dyslipidemia (Metoprolol) ```
179
B1 selective b-blockers | "1st half of alphabet"
``` Acebutolol Atenolol Betaxolol Esmolol Metoprolol ```
180
Nonselective b-blockers | "2nd half of alphabet"
Nadolol Pindolol Propranolol Timolol May cause... Hypoglycemia masking Cause hyperkalemia by interfering with B2 mediated K uptake in cells
181
Nonselective a/b-blockers - do not end in -olol Note - Can be used in Cocaine HTN
Carvedilol | Labetalol
182
Mechanism of Nebivolol
Cardiac-selective b1-blockade | Stimulation of b3 activating vascular NO synthase
183
Reversible inhibitors of H1 histamine receptors Note - May also be used in vestibular nausea
ANTIHISTAMINES First generation: Diphenhydramine, Dimenhydrinate, Chlorpheniramine, Hydroxyzine, Promethazine, Meclizine, Cyproheptadine Second generation: Loratadine, Fexofenadine, Desloratadine ``` First generation may cause... Sedation Antimuscarinic Anti-a-adrenergic (postural hypotension) Serotonergic (appetite stimulation) ```
184
Mechanism of Expectorants (Guaifenesin, NAC) Note - Do not suppress cough reflex
Guaifenesin - Thins respiratory secretions NAC - Mucolytic liquefies mucus in COPD patients by disrupting disulfide bonds
185
Mechanism of Dextromethorphan
Antitussive - NMDA receptor antagonist May cause... Serotonin syndrome Mild opioid effects (Naloxone as antidote)
186
Mechanism of Bosentan in treating PAH
Competitive antagonist of Endothelin-1 receptor leading to decreased pulmonary vascular resistance May cause... Hepatotoxicity
187
Mechanism of Sildenafil, Vardenafil, Tadalafil in treating ED Note - Tadalafil can also be used to treat PAH
Inhibits cGMP PDE-5, prolonging vasodilatory effect of NO via PKG ``` May cause... Flushing Headache Dyspepsia Cyanopica (blue-tinted vision) Hypotension with nitrates ```
188
Mechanism of Epoprostenol and Iloprost in treating PAH
PGI2 (Prostacyclin) with direct vasodilatory effects on pulmonary and systemic arterial vascular beds - inhibits platelet aggregation May cause... Flushing Jaw pain
189
Mechanism of inhaled corticosteroids
Fluticasone, Budesonide Inactivate NF-kB decreasing production of inflammatory cytokines (e.g. TNF-a)
190
Mechanism of muscarinic antagonists used to treat asthma/COPD
Ipratropium Competitively blocks muscarinic receptors preventing bronchoconstriction
191
Mechanism of Montelukast/Zafirlukast and Zileuton
Montelukast/Zafirlukast block LTD4 receptors (CysLT1) in ASA-induced asthma Zileuton is a 5-LOX inhibitor blocking conversion of arachidonic acid to leukotriene (hepatotoxicity) Note - Second line to steroids as drugs that work on late response to mediators (e.g. inflammation leading to bronchial hyperreactivity)
192
Mechanism and use of Omalizumab
Anti-IgE monoclonal antibody blocks binding to FceRI Allergic asthma resistant to inhaled corticosteroids and long-acting b2 agonists (e.g. Salmeterol, Formoterol)
193
Mechanism and use of of Mannitol
Increased tubular fluid osmolarity increases urine flow Elevated ICP or intraocular pressure Note - Contraindicated in anuria or HF due to risk of pulmonary edema
194
Mechanism and use of Acetazolamide
Carbonic anhydrase inhibitor causes self-limited NaHCO3 diuresis ``` Glaucoma Urinary alkalinization Metabolic alkalosis Pseudotumor cerebri Altitude sickness ``` May cause... Proximal RTA NH3 toxicity Sulfa allergy
195
Mechanism and use of sulfonamide loop diuretics Includes... Furosemide Bumetanide Torsemide Note - Inhibited by concurrent NSAID use
Inhibits NaK2Cl cotransporter in TALH Abolishes medullary hypertonicity (urinary concentration) Increases Ca excretion Edematous states Hypertension Hypercalcemia ``` May cause... Hypokalemic metabolic alkalosis (contraction) Ototoxicity Dehydration Allergy (sulfa) Interstitial nephritis Gout ```
196
Mechanism and use of Ethacrynic acid
Non-sulfa inhibitor of NaK2Cl cotransporter in TALH Diuresis in patients with sulfa allergies - higher risk of ototoxicity
197
Mechanism and use of Thiazides Includes... Hydrochlorothiazide Chlorthalidone Metolazone
Inhibits NaCl cotransporter in early DCT Decreases Ca excretion ``` Hypertension HF Calcium stones (hypercalciuria) Nephrogenic diabetes insipidus (free water loss) Osteoporosis ``` ``` May cause... Allergy (sulfa) Hyponatremia (maintain corticomedullary conc gradient) Hypokalemic metabolic alkalosis (contraction) Hypercalcemia (basolateral NCX) Hyperglycemia Hyperlipidemia Hyperuricemia ```
198
Mechanism and use of potassium-sparing diuretics Includes... Spironolactone/Eplerenone Triamterene/Amiloride
Spironolactone/Eplerenone competitive antagonists of aldosterone receptor in cortical collecting tubule Triamterene/Amiloride block ENaC in cortical collecting tubule ``` HF Hyperaldosteronism (Conn syndrome) Hypokalemia Hepatic ascites (Spironolactone) Nephrogenic diabetes insipidus (Amiloride) ``` May cause... Hyperkalemia Gynecomastia (Spironolactone) Metabolic acidosis
199
Mechanism and use of ACEi ``` Includes... Captopril Enalapril Lisinopril Ramipril ```
Prevents ACE conversion of ATI to ATII and inactivation of bradykinin - Increased Renin because of loss of feedback Hypertension Post-MI HF Diabetic nephropathy - Decreased intraglomerular pressure (afferent dilation) slows GBM thickening ``` May cause... First dose hypotension Cough Angioedema Hyperkalemia Increased Cr (decreased GFR) ARF if bilateral RAS Teratogen (fetal anuria) ``` Note - Angioedema (may be delayed) from increased bradykinin; contraindicated in C1 esterase inhibitor deficiency Note - Increased Cr/decreased GFR due to inability to preferentially constrict efferent arteriole (above 30% is dangerous)
200
Mechanism and use of ARBs Includes... Losartan Candesartan Valsartan
Selectively blocks ATII binding to AT1 receptor (smooth muscle, adrenal cortex) - No effect on bradykinin and good for patients with ACEi intolerance ``` Hypertension Post-MI HF Proteinuria Diabetic nephropathy (decreased intraglomerular pressure slows GBM thickening) ``` ``` May cause... Hypotension Hyperkalemia Increased Cr (decreased GFR) Teratogen ```
201
Mechanism and use of Aliskiren
Direct Renin inhibitor Hypertension May cause... Hypotension Hyperkalemia Increased Cr (decreased GFR)
202
Side effects of EPO
Thromboembolic events | Hypertension
203
Unpredictable drug interaction due to genetic differences or complex interactions
IDIOSYNCRATIC DRUG REACTION (TYPE B)
204
Mechanism and use of H2 blockers ``` Includes... Cimetidine Ranitidine Famotidine Nizatidine ```
Reversible blockade of Gs H2-receptors decreasing gastric acid secretion by parietal cells in response to Histamine from ECL cells Peptic ulcer Gastritis Mild esophageal reflux May cause... Antiadrenergic effects Decreased renal excretion of Cr (Cimetidine, Ranitidine)
205
Mechanism and use of PPI Includes... -prazole drugs
Irreversible inhibition of H/K ATPase in parietal cells Peptic ulcer Gastritis Esophageal reflux Zollinger-Ellison syndrome May cause... Increased C. diff risk Pneumonia Hypomagnesemia with long-term use
206
Side effects of antacids Includes... Aluminum hydroxide Calcium carbonate magnesium hydroxide
Hypokalemia Decreased drug bioavailability Delayed gastric emptying Aluminum hydroxide: Constipation Hypophosphatemia Osteodystrophy Calcium carbonate: Hypercalcemia (milk-alkali syndrome) Rebound HCl secretion Chelation of Tetracyclines Magnesium hydroxide: Diarrhea
207
Mechanism and use of Bismuth, Sucralfate
Binds to ulcer base providing physical barrier and allowing HCO3 secretion to reestablish pH gradient mucosal layer Ulcer healing Traveler's diarrhea
208
Mechanism and use of Misoprostol
PGE1 analog increasing production and secretion of gastric mucous, while decreasing gastric acid production (Gi) NSAID ulcer Induction of labor May cause... Diarrhea Abortifacient
209
Mechanism and use of Octreotide
Somatostatin analog - Decreases stomach, pancreatic, and gallbladder secretions Acute variceal bleeding VIPoma Carcinoid Acromegaly May cause... Steatorrhea Cholelithiasis (CCK inhibition)
210
``` Class of drugs including... Magnesium hydroxide Magnesium citrate Polyethylene glycol Lactulose ```
OSMOTIC LAXATIVES
211
Mechanism and use of Sulfasalazine
Combination of Sulfapyridine and 5-ASA activated by colonic bacteria UC Crohn's colitis May cause... Sulfonamide toxicity Reversible oligospermia
212
Mechanism and use of Loperamide
u-opioid agonist slowing gut motility - Poor CNS penetration means low addictive potential Good for IBS, Diarrhea
213
Mechanism and use of Ondansetron
5-HT3 antagonist decreasing vagal stimulation in area postrema Antiemetic (postoperative, chemotherapy) May cause... Prolonged QT
214
Mechanism and use of Metoclopramide/Prochlorperazine
D2 receptor antagonist... Increases LES tone Decreases pyloric tone Increases peristalsis (no effect on colonic transit time), Inhibits D2 action in area postrema (near NTS) ``` Diabetic/Postoperative gastroparesis Central antiemetic (e.g. migraines) ``` ``` May cause... Parkinsonism (contraindicated) Tardive dyskinesia Sedation Contraindicated in small bowel obstruction ``` Note - Drug interactions with Digoxin, diabetic agents
215
Mechanism and use of Orlistat
Inhibits gastric and pancreatic lipase decreasing absorption of dietary fats (weight loss) May cause... Steatorrhea Vit A, D, E, K deficiency
216
Mechanism and use of Ursodiol (ursodeoxycholic acid)
Nontoxic bile acid - Increases bile secretion and decreases cholesterol secretion Primary biliary cirrhosis Gallstone prevention or dissolution
217
Mechanism of Theophylline (bronchial asthma)
Inhibition of cAMP phosphodiesterase - Results in bronchodilation May cause... GI disturbance Seizure Arrhythmias Note - Metabolized by Cytochrome P-450
218
Mechanism of rapid absorption of Lispro, Aspart, Glulisine
Proline residues to prevent polymerization (e.g. Regular) and allow rapid absorption Note - Absorption is delayed in long-acting forms by adding Protamine (NPH), fatty acid (Detemir), Acidic groups (Glargine)
219
Insulin used in... DKA Hyperkalemia Stress hyperglycemia
Regular insulin - IV form available
220
Mechanism of drugs including... | Metformin
BIGUANIDES Increases peripheral glucose uptake and insulin sensitivity (no islet cell function needed) while decreasing gluconeogenesis - Causes modest weight loss May cause... GI disturbance Lactic acidosis in renal insufficiency Note - Always obtain baseline renal function tests
221
``` Mechanism of drugs including... GlimepirIDE GlipizIDE GlyburIDE ChlorpropamIDE TolbutamIDE ```
SULFONYLUREAS Close K channel in beta cell membranes causing cell depolarization and Ca influx - endogenous insulin release so need some islet cell function (e.g. not T1DM) May cause... Weight gain Hypoglycemia (especially in renal insufficiency)
222
Mechanism of drugs including... PiogliTAZONE RosigliTAZONE
GLITAZONES/THIAZOLIDINEDIONES Binds PPAR-y nuclear transcription regular leading to... Insulin sensitivity (GLUT4) Adiponectin production (b-oxidation) Decreased TNF-a, Leptin ``` May cause... Weight gain (Leptin) Edema HF exacerbation Osteoporosis No risk of hypoglycemia ``` Note - Safe to use in renal insufficiency
223
Mechanism of drugs including... NateGLINIDE RepaGLINIDE
MEGLITINIDES Bind different K channel site than Sulfonylureas - Useful for post-prandial high glucose (short-acting) May cause... Weight gain Hypoglycemia (especially in renal insufficiency)
224
Mechanism of drugs including... ExenaTIDE LiragluTIDE
GLP-1 ANALOGS Bind G-protein and increased glucose-dependent insulin release while inhibiting glucagon - Causes modest weight loss May cause... Nausea/Vomiting (inhibit gastric emptying) Pancreatitis
225
Mechanism of drugs including... LinagLIPTIN SaxagLIPTIN SitagLIPTIN
DPP-4 INHIBITORS Inhibits DPP-4 enzyme that deactivates GLP-1 May cause... Nasopharyngitis Note - No hypoglycemia because glucose-dependent
226
Mechanism of drugs including... | Pramlintide SQ injection
AMYLIN ANALOGS Decreased gastric emptying and glucagon May cause... Hypoglycemia Nausea
227
Mechanism of drugs including... CanaGLIFLOZIN DapaGLIFLOZIN EmpaGLIFLOZIN
SGLT-2 INHIBITORS ``` May cause... Glucosuria UTIs/Vaginal yeast infections Hyperkalemia Orthostatic hypotension (dehydration) ``` Note - Always get baseline renal function tests as these drugs need a working PCT to be effective
228
Mechanism of drugs including... Acarbose Miglitol
A-GLUCOSIDASE INHIBITORS Inhibit intestinal brush-border a-glucosidases delaying carbohydrate hydrolysis and glucose absorption - leads to decreased postprandial hyperglycemia May cause... GI upset
229
Mechanism of PTU and Methimazole
THIONAMIDES Block thyroid peroxidase preventing oxidation and organification of iodine PTU/Propranolol also blocks 5-deiodinase decreasing peripheral conversion of T4 to T3 ``` May cause... Agranulocytosis (sore throat, fever) ANCA vasculitis Skin rash Aplastic anemia Hepatotoxicity Cholestasis Teratogen (Methimazole) ```
230
Mechanism of drugs including... Conivaptan Tolvaptan
ADH ANTAGONISTS Used in SIADH to block action at V2 receptor
231
``` Treats... Acromegaly Carcinoid syndrome Gastrinoma Glucagonoma Esophageal varices ```
OCTREOTIDE Inhibits GH and release of most GI hormones
232
Mechanism of Demeclocycline
ADH ANTAGONIST (TETRACYCLINE) May cause... Photosensitivity Bone and teeth abnormalities
233
Side effects of glucocorticoids
``` Cushing syndrome Adrenocortical atrophy Peptic ulcers Steroid diabetes Steroid psychoses Cataracts ```
234
Mechanism and use of Fludrocortisone
ALDOSTERONE ANALOG Mineralocorticoid replacement in primary adrenal insufficiency ``` May cause... Edema HF Hyperpigmentation Cortisol-like effects ```
235
Mechanism and use of Cinacalcet
Sensitizes Ca-sensing receptor (CaSR) in parathyroid gland decreasing PTH - Useful for dialysis patients May cause... Hypocalcemia Note - Sevelamer binds phosphate to decrease GI absorption in dialysis patients
236
``` Mechanism of drug used for... Uterine fibroids Endometriosis Precocious puberty Prostate cancer Infertility ```
LEUPROLIDE GnRH analog which is an agonist when pulsatile, and antagonist when continuous
237
Mechanism of Clomiphene in PCOS
Hypothalamic estrogen receptor antagonist - prevents feedback inhibition of LH and FSH ``` May cause... Multiple pregnancies Visual disturbances Hot flashes Ovarian enlargement ```
238
Difference in mechanism of Tamoxifen (breast cancer) and Raloxifene (osteoporosis)
Tamoxifen is an estrogen receptor antagonist at the breast, but agonist at bone and uterus - increases the risk of DVT and endometrial cancer Raloxifene is an estrogen receptor antagonist at the breast and uterus, but agonist at bone - increases risk of DVT only Note - SERMs can also be used to treat gynecomastia in ADT patients
239
Mechanism and use of drugs including... Anastrozole Letrozole Exemestane
AROMATASE INHIBITORS ER+ breast cancer in postmenopausal women
240
Mechanism of drug used for... Endometrial cancer Abnormal uterine bleeding Contraception
PROGESTINS Includes Levonorgestrel, Medroxyprogesterone, Etonogestrel, Norethindrone, and Megestrol Decreases growth of endometrium, thickens cervical mucus (mini-pill, IUD), and decreases LH/FSH (combined OCP) Note - Presence of withdrawal bleeding excludes anatomic defects (e.g. Asherman) and chronic anovulation
241
Mechanism of Terbutaline/Ritodrine
B2-agonists that relax the uterus - Decreases contraction frequency during labor
242
Mechanism of Danazol Used to treat... Endometriosis Angioedema
Synthetic androgen that acts as partial agonist at androgen receptor ``` May cause... Hepatotoxicity Decreased HDL Weight gain Edema Acne, hirsutism, masculinization ```
243
Stimulates anabolism to promote recovery after burn or injury
TESTOSTERONE, METHYLTESTOSTERONE
244
Mechanism of drugs used in PCOS to reduce androgenic symptoms
Ketoconazole - Inhibits steroid synthesis by Desmolase Spironolactone - Inhibits steroid binding, 17a-hydroxylase, and Desmolase May cause... Gynecomastia Amenorrhea
245
Mechanism of Finasteride - BPH and male pattern baldness
5a-reductase inhibitor decreases conversion of testosterone to DHT
246
Used to treat... Androgenetic alopecia Severe refractory hypertension
MINOXIDIL Direct arteriolar vasodilator
247
Mechanism of Acetaminophen
Reversible COX inhibitor - CNS only so not anti-inflammatory
248
Mechanism and dosages of ASA
Irreversible COX1/2 inhibitor by covalent acetylation ``` Low dose (< 300) - Decreases platelet aggregation Medium dose (< 2400) - Antipyretic and Analgesic High dose (< 4000) - Antiinflammatory ``` ``` May cause... Increased bleeding time (normal PT, PTT) Gastric ulceration Tinnitus Interstitial nephritis Respiratory alkalosis early in overdose Mixed metabolic alkalosis-respiratory acidosis later ```
249
Mechanism of Celecoxib Used to treat... Rheumatoid arthritis Osteoarthritis
Reversible inhibition of COX2 - Inducible by IL-1/TNF-a Spares COX1 (constitutive) - Maintains gastric mucosa and produces TXA2 May cause... Thrombosis Impaired renal perfusion Sulfa allergy
250
Mechanism of NSAIDs ``` Includes... Ibuprofen Naproxen Indomethacin Ketorolac Diclofenac Meloxicam Piroxicam ```
Reversible inhibition of COX1/2 May cause... Gastric ulceration Interstitial nephritis Renal ischemia Note - Naproxen, Indomethacin can be used for acute gout attacks
251
Mechanism of Leflunomide
Reversibly inhibits Dihydroorotate Dehydrogenase - disrupts Pyrimidine synthesis and T cell proliferation Rheumatoid arthritis Psoriatic arthritis ``` May cause... Diarrhea Hypertension Hepatotoxicity Teratogen ```
252
Mechanism of Bisphosphonates ``` Includes... Alendronate Ibandronate RIsedronate Zoledronate ```
Pyrophosphate analog binds Hydroxyapatite in bone - inhibits osteoclast activity ``` Osteoporosis Hypercalcemia Paget (osteitis deformans) Metastatic bone disease Osteogenesis imperfecta ``` May cause... Pill esophagitis (take with water, sit upright after) Osteonecrosis of jaw Atypical stress fractures
253
Mechanism of Teriparatide - stimulates bone growth in Osteoporosis
Recombinant PTH analog - increases osteoblastic activity May cause... Transient hypercalcemia
254
Mechanism of Allopurinol and Febuxostat
Competitive inhibitor of Xanthine Oxidase preventing conversion of Hypoxanthine and Xanthine to Urate Used in... Gout control Uric acid stones Lymphoma/Lymphoma (tumor lysis syndrome) May cause... DRESS (fever, lymphadenopathy, rash, organ dysfunction) Note - Also increases levels of Azathioprine and 6-Mercaptopurine as they are metabolized by Xanthine Oxidase
255
Mechanism of Pegloticase, Rasburicase
Recombinant Uricase converts Urate to Allantoin - more water soluble Pegloticase - Gout control Rasburicase - Tumor lysis
256
Mechanism of Probenecid
Binds OAT - Inhibits reabsorption of uric acid in PCT Gout control May cause... Uric acid stones Note - Diuretics and ASA prevent tubular secretion
257
Mechanism of Colchicine
Binds and stabilizes Tubulin - Inhibits microtubule polymerization and thus Neutrophil chemotaxis and degranulation Acute gout attack May cause... GI disturbance
258
Mechanism of TNF-a inhibitor used to treat... Rheumatoid arthritis Ankylosing spondylitis Psoriasis
ETANERCEPT Fusion protein (TNF-a receptor, IgG Fc) acts as TNF decoy receptor
259
Mechanism of TNF-a inhibitors used to treat... IBD Rheumatoid arthritis Ankylosing spondylitis Psoriasis
INFLIXIMAB, ADALIMUMAB Anti-TNFa monoclonal antibody
260
Mechanism of drug used for... Acute PE ACS DVT Note - Can be used in pregnancy
HEPARIN Inhibits II (Thrombin) and Xa - Follow PTT May cause... HIT Bleeding Osteoporosis Note - Antidote is Protamine sulfate
261
Class of drugs including... Enoxaparin Dalteparin Fondaparinux
LMWH More specific for Xa - Does not require lab monitoring Note - Better bioavailability and longer half life, but no antidote
262
Mechanism of drug used for... PE/DVT Afib Note - Can be used in HIT
DIRECT THROMBIN INHIBITORS Argatroban Dabigatran Bivalirudin Does not require lab monitoring May cause... Bleeding Note - No antidote, but may attempt activated prothrombin complex concentrate (PCC) or fibrinolytics (tranexamic acid)
263
Mechanism of drug used for... DVT/PE prophylaxis Afib stroke prevention
WARFARIN Prevents y-carboxylation of Vit K - acts in liver May cause... Bleeding Skin/tissue necrosis Teratogen (stippled epiphyses) Note - Reverse rapidly with FFP, slowly with Vit K
264
Mechanism of drugs including... Apixaban Rivaroxaban Note - Do not affect TT
DIRECT FACTOR XA INHIBITORS DVT/PE prophylaxis Afib stroke prevention May cause... Bleeding Note - No reversal agent
265
``` Mechanism of drugs including... Alteplase Reteplase Streptokinase Tenecteplase ```
THROMBOLYTICS Aid conversion of plasminogen to plasmin cleaving thrombin and fibrin clots - Follow PT and PTT ``` Avoid if... Bleeding risk Severe hypertension (ICH) ``` Treat toxicity with Aminocaproic acid, and possible FFP/Cryo Note - Platelet count normal
266
``` Mechanism of drugs including... Clopidogrel Prasugrel Ticagrelor (reversible) Ticlopidine ```
ADP RECEPTOR INHIBITORS Irreversible blockade of ADP receptors on platelets prevents expression of GpIIb/IIIa ACS Coronary stenting Thrombotic stroke prophylaxis May cause... Neutropenia (Ticlopidine) TTP
267
Mechanism of drugs including... Milrinone Cilostazol Dipyridamole
Phosphodiesterase III inhibitors - Increase cAMP results in increased contractility, arterial vasodilation, and decreased platelet aggregation Intermittent claudication Vasodilation Stroke/TIA prevention (with ASA) ``` May cause... Nausea Headache Facial flushing Hypotension Abdominal pain ```
268
Mechanism of drugs including... Abciximab Eptifibatide Tirofiban
GPII/IIIA INHIBITORS Bind to receptors and prevent platelet aggregation - Abciximab is made from monoclonal antibody Fab fragments Unstable angina Coronary angioplasty May cause... Bleeding Thrombocytopenia
269
Mechanism of antimetabolite (S phase) used to treat... Transplant rejection prophylaxis Rheumatoid arthritis IBD SLE Note - Used to wean off steroids or treat steroid-refractory chronic disease
AZATHIOPRINE 6-Mercaptopurine (metabolite of Azathioprine) Purine analog activated by HGPRT - Prevents de novo purine synthesis May cause... Myelosuppression GI toxicity Liver toxicity Note - Metabolized by Xanthine Oxidase so increased toxicity with Allopurinol or Febuxostat Note - Mutation in Thiopurine Methyltransferase also increase toxicity
270
Mechanism of antimetabolite (S phase) used to treat... Hairy cell leukemia
CLADRIBINE Purine analog inhibitor of DNA polymerase May cause... Myelosuppression Nephrotoxicity Neurotoxicity
271
Mechanism of antimetabolite (S phase) used to treat... AML Lymphoma
CYTARABINE (ARABINOFURANOSYL CYTIDINE) Pyrimidine analog inhibitor of DNA polymerase May cause... Myelosuppression Megaloblastic anemia Pancytopenia
272
Mechanism of antimetabolite (S phase) used to treat... Colon cancer Pancreatic cancer BCC (topical)
5-FLUOROURACIL Pyrimidine analog bioactivated to 5-FdUMP and inhibits Thymidylate Synthesis - Decreased dUMP to dTMP May cause... Myelosuppression especially with Leucovorin Note - Potentiated with Leucovorin
273
Mechanism of antimetabolite (S phase) used to treat... ``` ALL Lymphoma Choriocarcinoma Sarcoma Rheumatoid arthritis Psoriasis IBD Vasculitis Ectopic pregnancy Medical abortion (with Misoprostol) ```
METHOTREXATE Folic acid analog competitively inhibits Dihydrofolate Reductase - Decreased dTMP synthesis ``` May cause... Myelosuppression Hepatotoxicity Mucositis (mouth ulcers) Pulmonary Fibrosis ``` Note - Rescue with Leucovorin
274
Mechanism of drug used to treat... Testicular cancer Hodgkin's lymphoma
BLEOMYCIN Induces free radical formation leading to breaks in DNA strands - works in G2 phase May cause... Pulmonary fibrosis Skin hyperpigmentation Note - Minimal myelosuppression
275
Mechanism of drug used to treat... Wilms tumor Ewing sarcoma Rhabdomyosarcoma
DACTINOMYCIN (ACTINOMYCIN D) Intercalates in DNA May cause... Myelosuppression
276
Mechanism of drug used to treat... Solid tumors Leukemias Lymphomas
DOXORUBICIN/DAUNORUBICIN Generates free radicals and intercalates with DNA May cause... Cardiotoxicity - prevent with Dexrazoxane Myelosuppression Alopecia
277
Mechanism of Alkylating agent (DNA cross-linking) used to treat... CML Bone marrow ablation pre-transplant
BUSULFAN May cause... Severe myelosuppression Pulmonary fibrosis Hyperpigmentation
278
Mechanism of Alkylating agent (DNA cross-linking) used to treat... Solid tumors Leukemia Lymphoma
CYCLOPHOSPHAMIDE, IFOSFAMIDE Requires bioactivation by liver May cause... Myelosuppression Hemorrhagic cystitis - prevent with Mesna or NAC
279
Mechanism of Alkylating agent (DNA cross-linking) used to treat... Brain tumors (GBM)
NITROSOUREAS Requires bioactivation - crosses BBB May cause... Convulsions Dizziness Ataxia
280
Mechanism of microtubule inhibitors (M phase) used to treat... Ovarian carcinomas Breast carcinomas
PACLITAXEL/TAXOLS Hyperstability polymerized microtubules to prevent anaphase May cause... Myelosuppression Neuropathy Hypersensitivity
281
Mechanism of microtubule inhibitors (M phase) used to treat... Solid tumors Leukemias Hodgkin's lymphoma Non-Hodgkin's lymphoma
VINCRISTINE/VINBLASTINE Bind b-tubulin and inhibit polymerization preventing mitotic spindle formation May cause... Peripheral neuritis, areflexia Paralytic ileus Note - Vincristine for Hodgkin's, Vinblastine for non-Hodgkin's
282
Mechanism of Platinum agent used to treat... Testicular cancer Bladder cancer Ovarian cancer Lung cancer
CISPLATIN, CARBOPLATIN Cross-links DNA May cause... Nephrotoxicity - Prevent with Amifostine/Diuresis Ototoxicity Peripheral neuropathy
283
Mechanism of Topoisomerase inhibitor (S to G2) used to treat... SCLC Testicular cancer Leukemia Lymphoma
ETOPOSIDE, TENIPOSIDE Inhibits Top II increasing DNA degradation May cause... Myelosuppression Alopecia
284
Mechanism of Topoisomerase inhibitor (S to G2) use to treat... SCLC Colon cancer Ovarian cancer
IRINOTECAN, TOPOTECAN Inhibits Top I preventing DNA unwinding and replication May cause... Severe myelosuppression Diarrhea
285
Mechanism of antimetabolite (S phase) used to treat... Melanoma CML SCD
HYDROXYUREA Inhibits Ribonucleotide Reductase (UDP to dUDP) - Decreasing DNA synthesis (S-phase specific) Also increases HbF May cause... Severe myelosuppression
286
Mechanism of Bevacizumab Used to treat... Colorectal cancer RCC
Antibody against VEGF - Inhibits angiogenesis May cause... Hemorrhage Blood clots Impaired wound healing Note Bevacizumab/Ranibizumab may both also treat wet macular degeneration
287
Mechanism of Erlotinib Used to treat... Non-small cell lung cancer
EGFR tyrosine kinase inhibitor May cause... Rash
288
Mechanism of Cetuximab Used to treat... CRC (wild-type KRAS) Head and neck cancer
Monoclonal antibody against EGFR May cause... Rash Elevated LFTs Diarrhea
289
Mechanism of Imatinib Used to treat... CML GIST
Tyrosine kinase inhibitor of bcr-abl and c-kit May cause... Fluid retention
290
Mechanism of Rituximab ``` Used to treat... Non-hodgkin's lymphoma CLL Rheumatoid arthritis ITP ```
Monoclonal antibody against CD20 - B-cell marker May cause... Increased risk of PML
291
Mechanism of Trastuzumab (Herceptin) Used to treat... HER2+ breast cancer Gastric cancer
Monoclonal antibody against HER-2 (c-erbB2) tyrosine kinase receptor - prevents intracellular signaling and induces antibody-dependent cytotoxicity May cause... Cardiotoxicity
292
Mechanism of Vemurafenib Used to treat... Metastatic melanoma
Small molecule inhibitor of BRAF oncogene+ (V600E) melanoma
293
Mechanism of opioid analgesics ``` Includes... Morphine Fentanyl Codeine Methadone Meperidine (mydriatic) Dextromethorphan Diphenoxylate (anti-diarrheal) Loperamide (anti-diarrheal) Pentazocine ```
Decreases synaptic transmission by closing pre-synaptic Ca channels and opening post-synaptic K channels Note - No tolerance to miosis or constipation Note - May cause biliary colic (sphincter of Oddi contraction)
294
Mechanism of Pentazocine
k-opioid agonist and u-opioid antagonist May cause... Opioid withdrawal with full antagonist
295
Mechanism of Butorphanol
k-opioid agonist and u-opioid partial agonist Used in severe pain - Partial agonist so less respiratory depression May cause... Opioid withdrawal with full agonist
296
Mechanism of Tramadol
Very weak opioid agonist Serotonin and NE reuptake inhibitor May cause... Opioid symptoms Decreases seizure threshold Serotonin syndrome
297
Mechanism and side effects of Ethosuximide
Blocks thalamic T-type Ca-channels ``` May cause... GI disturbance Headache Urticaria SJS ```
298
Mechanism and side effects of Phenytoin
Blocks Na channels - Zero order kinetics ``` May cause (Dose-dependent saturation)... CNS symptoms (ataxia, nystagmus) Megaloblastic anemia Gingival hyperplasia Hirsutism SJS DRESS Teratogen (NTD, craniofacial, nail hypoplasia) ``` Note - Metabolized by Cytochrome P-450
299
Mechanism and side effects of Carbamazepine
Blocks Na channels increasing refractory period ``` May cause... Agranulocytosis/Aplastic anemia Hepatotoxicity SJS DRESS SIADH Teratogen ```
300
Mechanism and side effects of Valproate
Induces Na channels Inhibits GABA transaminase increasing GABA ``` May cause... GI distress Fetal hepatotoxicity - measure LFTs Pancreatitis Weight gain Tremor Teratogen (neural tube defects) ``` Note - Vigabatrin also inhibits GABA transaminase
301
Mechanism and side effects of Gabapentin
Inhibits voltage-gated Ca channels - acts as GABA analog May cause... Sedation Ataxia
302
Mechanism and side effects of Topiramate
Blocks Na channels Increases GABA activity May cause... Sedation Mental dulling Kidney stones Note - Tiagabine inhibits GABA reuptake
303
Mechanism and side effects of Lamotrigine
Blocks Na channels May cause... SJS
304
Mechanism and side effects of Barbiturates ``` Includes... Phenobarbital Pentobarbital Thiopental secobarbital ```
Facilitates GABA by increasing Cl channel duration May cause... Respiratory depression CV depression
305
Benzodiazepines not metabolized by the liver - Safe to use in alcohol withdrawal with liver failure
Lorazepam Oxazepam Temazepam Note - Normally Diazepam/Chlordiazepoxide prefered due to self-tapering profile
306
Benzodiazepines that have a high addictive potential (short acting)
Triazolam Oxazepam Midazolam (endoscopy) Alprazolam Lorazepam Temazepam Note - Less active metabolites
307
Mechanism of nonbenzodiazepine hypnotics Includes... Zolpidem Zaleplon Eszopiclone
ACt on BZI subtype of GABA receptor May cause... Ataxia Headaches Confusion Note - Alternative is Ramelteon (melatonin agonist)
308
Determinant of induction speed and potency of inhaled anesthetics
Decreased solubility in blood - Rapid induction Increased solubility in lipids - Increased potency Note - Potency = 1/MAC
309
``` Side effects of drugs including... Halothane Methoxyflurane Enflurane N2O ```
INHALED ANESTHETICS ``` Hepatotoxicity (centrilobular) Nephrotoxicity Proconvulsant Expansion of trapped gas in body cavities Hypotension ``` Note - Increase cerebral blood flow
310
IV anesthetic used for... ICU Rapid induction Short procedures
PROPOFOL Potentiates GABA - High lipophilicity rapidly redistributes from high flow organs (brain, heart, liver, kidneys) to lower flow organs (muscle, skin, fat) Note - Less postoperative nausea
311
High potency IV anesthetic used for induction and short procedures - Effect terminated by rapid redistribution into tissue and fat
THIOPENTAL Note - Decreases cerebral blood flow
312
Order of nerve blockade by local anesthetics Includes... Esters (Procaine, Cocaine, Tetracaine, Benzocaine) Amides (Lidocaine, Mepivacaine, Bupivacaine) Note - If allergic to Ester can give Amide
Small myelinated fibers Small unmyelinated fibers Large myelinated fibers Large unmyelinated fibers Note - Loss of sensation (first to last) is Pain > Temperature > Touch > Pressure
313
Reason for increased local anesthetic dose in infected tissue
Acidic tissue makes alkaline anesthetics more charged and thus unable to penetrate the membrane Note - Block inner portion of channel
314
Mechanism of Succinylcholine
POLARIZING NEUROMUSCULAR BLOCKER Strong Ach receptor agonist produces sustained depolarization Diminished TOF response (phase I) followed by progressive reduction (phase II) Can only reverse with AcheE inhibitors in Phase II (repolarized but desensitized) May cause... Hyperkalemia Hypercalcemia Malignant hyperthermia
315
Mechanism of drugs including... Tubocurarine -urium drugs
NONDEPOLARIZING NEUROMUSCULAR BLOCKERS Competitive antagonists of Ach receptors - Reverse with AchE inhibitor (Neostigmine, Edrophonium) Progressive reduction with TOF due to additional presynaptic blockade May cause... Flushing Bronchoconstriction Hypotension Note - Give AchE inhibitor (Physostigmine, Neostigmine) with Atropine to prevent muscarinic toxicity
316
Mechanism of Baclofen
Activates GABA-b receptors at spinal cord level - Induces skeletal muscle relaxation Note - Cyclobenzaprine is a central acting relaxant (TCA-like) Note - Tizanidine (a2 agonist) also used
317
``` Mechanism of Parkinson's drugs... Bromocriptine Pramipexole/Ropinirole Amantadine Carbidopa Selegiline Entacapone/Tolcapone Benztropine ``` Note - L-Dopa converted to Dopamine by DOPA decarboxylase
``` Dopamine agonist (Ergot) Dopamine agonist (non-Ergot) Increased Dopamine release, Decreased uptake Peripheral DOPA decarboxylase inhibitor MAO-B inhibitors COMT inhibitors (peripheral, central) Antimuscarinic - Tremor/Rigidity ``` Note - Amantadine may cause Ataxia/Livedo Reticularis
318
Mechanism of Alzheimer's drugs... Memantine Donepezil, Galantamine, Rivastigmine, Tacrine
``` NMDA antagonist (Confusion, Hallucinations) AChE inhibitors ```
319
Treatment (4) of HTN in pregnancy
Hydralazine Labetalol Methyldopa Nifedipine
320
Treatment of... Arsenic poisoning Lead poisoning Iron poisoning
Dimercaprol (British anti-Lewisite) or DMSA EDTA, Succimer Deferoxamine
321
Mechanism of Aprepitant/Fosaprepitant
Neurokinin 1 (NK1) receptor antagonists in area postrema Chemotherapy antiemetic
322
Mechanism of Varenicline - Smoking cessation
Partial nicotinic acetylcholine receptors - Reduces cravings and rewards (competitive)
323
Naming of biological agents... - mab - cept - nib
Monoclonal antibody Receptor molecule Kinase inhibitor Note - For antibodies, -xi- is chimeric -zu- is humanized
324
Effect of... High blood/gas partition coefficient High AV conc gradient
Highly soluble gas saturates the blood more slowly leading to slower brain saturation and thus onset time Higher solubility in peripheral tissues means more drug is needed for blood saturation thus increasing onset time
325
Causes of Drug-Induced SLE
Hydralazine Procainamide Isoniazid Note - Slow acetylators
326
Mechanism of Capsaicin
Depletion of Substance P
327
Calcium channel blockers used for... Angina (e.g. Prinzmetal's) Raynaud's Hypertension
DIHYDROPYRIDINES Amlodipine, Clevidipine, Nicardipine, Nifedipine, Nimodipine (Post-SAH) May cause... Peripheral edema Flushing/Dizziness Gingival hyperplasia
328
Mechanism of Hydralazine Used for... Severe HRN HF
Increases cAMP causing smooth muscle relaxation - Mostly affects Arterioles (afterload) May cause... Reflex tachycardia (Angina/CAD) Fluid retention Angina
329
Mechanism of Ranolazine Used for... Refractory angina
Inhibits late phase of Na current - Reduces diastolic wall tension and oxygen consumption with no effect on HR or Inotropy May cause... Long QT
330
Mechanism of drug resistance to hydrophobic chemotherapeutics (e.g. Anthracyclines)
MDR1 P-glycoprotein (ATP efflux pump)
331
Mechanism and side effect of Cholestyramine, Colestipol, and Colesevelam
BILE ACID RESINS Liver uses cholesterol to make more bile acid Upregulates HMG-CoA (synergy) May cause... Hypertriglyceridemia GI upset Malabsorption Note - Ezetimibe inhibits cholesterol absorption directly instead of bile acid resins but may cause transaminitis
332
Mechanism and side effect of drugs used to lower TG Includes... Gemfibrozil Bezafibrate Fenofibrate
FIBRATES Upregulates LPL to increase TG clearance Activates PPAR-a to decrease hepatic VLDL production Induce HDL synthesis May cause... Myopathy (with Statins) Cholesterol gallstones
333
Mechanism and side effect of drugs used to decrease LDL and increase HDL
NIACIN (VIT B3) Inhibits hormone sensitive lipase Reduces hepatic VLDL production May cause... Red, flushed face (treat with NSAID) Hyperglycemia Hyperuricemia
334
Mechanism of Digoxin in treating HF and Afib Note - Eliminated by kidney
HF - Increased Ca release from SR increases inotropy Afib - Increased vagal tone decreases HR ``` May cause... Cholinergic syndromes Color abnormalities AT with AV block Hyperkalemia (poor prognosis) ```
335
Mechanism and side effects of Class IA antiarrhythmics used for... Re-entrant/ectopic SVT and VT ("Queen Proclaims the Pyramids)
Na channel blockade... Increased AP duration Slowed conduction speed Increased QT interval Includes... Quinidine, Procainamide (WPW), Disopyramide May cause... Cinchonism (Headache, Tinnitus) SLE Torsades Note - Treat Torsades with Mg
336
Mechanism and side effects of Class IB antiarrhythmics used for... ``` Acute VT (post-MI) Digitalis toxicity ``` ("Lettuce Tomato Mayo") Note - Not for SVT
Na channel blockade... Decreased AP duration Normal conduction speed Preferentially affects ischemic tissue Includes... Lidocaine, Tocainide, Mexiletine May cause... CNS symptoms CV depression
337
Mechanism and side effects of Class IC antiarrhythmics used for... Paroxysmal Afib ("More Fries Please")
Na channel blockade... Normal AP duration Slowed conduction speed Preferentially affects AV node and accessory tracts Includes... Moricizine, Flecainide, Propafenone May cause... Arrhythmias post MI Contraindicated in structural/ischemic heart disease Note - Stronge use-dependence - Due to slow dissociation from Na channels increased HR increases effect of drug (wide QRS)
338
Mechanism and side effects of Class II antiarrhythmics used for... Rate control (Afib, Aflutter)
B-blockers... Decreased slope of phase 4 - Slowed sinus discharge Decreased cAMP - Slows conduction and prolongs ERP ``` May cause... Impotence COPD/Asthma Bradycardia Hypoglycemia masking (CNS sedation) Dyslipidemia (Metoprolol) Vasospasm (Propranolol) ``` Note - Treat overdose with Atropine/Glucagon
339
Mechanism and side effects of Class III antiarrhythmics used for... Afib, Aflutter VT ("AIDS")
K channel blockers... Increased AP duration Normal conduction velocity Increased QT interval Includes... Amiodarone, Ibutilide, Dofetilide, Sotalol ``` May cause... Bradycardia Pulmonary fibrosis (Amiodarone) Hepatotoxicity (Amiodarone) Thyroid toxicity (Amiodarone) Photodermatitis (Amiodarone) Lower Torsades risk ``` Note - Check LFTs, PFTs, and TFTs before using Amiodarone Note - Show reverse use-dependency so slower HR results in more prolonged QT
340
Mechanism and side effects of class IV antiarrhythmics used for... ``` Hypertension Angina Paroxysmal SVT Afib with RVR Aflutter ```
Non-dihydropyridines (Verapamil, Diltiazem)... Slowed sinus discharge Slows conduction and prolongs ERP ``` May cause... Constipation Bradycardia AV block Contraindicated in CHF (negative inotrope) ``` Note - May mask ischemia during stress test
341
Mechanism and side effects of Adenosine used for... Diagnosing or rapid termination of SVTs
Increased K efflux hyperpolarizes cell and decreases Ca influx ``` May cause... Flushing Hypotension Chest pain Sense of impending doom Bronchospasm ``` Note - Decreased effectiveness with Caffeine and Theophylline
342
Mechanism of Nitrates in treating CN toxicity
Converts Fe2+ to Fe3+ (MetHb) which binds CN removing it from Cytochrome C Oxidase in ETC
343
Mechanism of Cyclosporine and Tacrolimus Used for... Transplant rejection prophylaxis Psoriasis Rheumatoid arthritis
CALCINEURIN INHIBITOR (NFAT) Blocks T-cell activation by inhibiting IL-2 transcription ``` May cause... Nephrotoxicity Neurotoxicity Metabolic disorder Gingival hyperplasia (Cyclosporine) Myopathy (with Statins) ```
344
Mechanism of Sirolimus (Rapamycin) Used for... Kidney transplant rejection prophylaxis Note - Not nephrotoxic
MTOR INHIBITOR Blocks T-cell activation and B-cell proliferation by inhibiting response to IL-2 May cause... Pancytopenia Metabolic disorder
345
Mechanism of Daclizumab, Basiliximab Used for... Kidney transplant rejection prophylaxis
Monoclonal antibodies blocking IL-2 May cause... Edema HTN Tremor
346
Mechanism of Mycophenolate Used for... Transplant rejection prophylaxis SLE nephritis
Inhibits IMP dehydrogenase preventing purine synthesis ``` May cause... GI upset Pancytopenia Invasive CMV infection Metabolic disorder ```
347
Use of Filgrastim/Sargramostim
Recovery of bone marrow
348
Use of... IFN-a IFN-b IFN-y
HCV, HBV, Kaposi, Melanoma MS Chronic granulomatous disease
349
Use of... Romiplostim Eltrombopag Oprelvekin
Thrombocytopenia
350
Mechanism of Natalizumab Used for... MS Crohn's
Antibody against a4-integrin (WBC adhesion) May cause... PML (JC virus)
351
Mechanism of Denosumab Used for... Osteoporosis
Antibody against RANKL - Inhibits osteoclast maturation by mimicking Osteoprotegerin
352
Mechanism of Palivizumab
Antibody against RSV F protein - For high risk-infants
353
Mechanism of Statins
Prevent conversion of HMG-CoA to Mevalonate Upregulation of LDLR further reduces circulating LDL
354
Drugs causing osteoporosis by... ``` Increasing Vit D catabolism Decreasing Estrogen Decreasing Testosterone and Estrogen Decreasing Ca absorption Decreasing bone formation ```
Phenobarbital, Phenytoin, Carbamazepine (CYP-450) Aromatase inhibitors, Medroxyprogesterone GnRH agonists PPIs Steroids, Unfractionated Heparin, Thiazolidinediones